Other
Concentration
0
Pipeline Programs↗
26
Active Trials↗
41
Companies Involved↗
Concentration is an early-stage landscape with 0 programs across 41 companies. The most active players are Pfizer, Astellas, AstraZeneca.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
331
clinical trials
Completed241 · 73%
Unknown status32 · 10%
Terminated20 · 6%
Recruiting15 · 5%
Withdrawn11 · 3%
Active, not recruiting5 · 2%
Other7 · 2%
Clinical Trials
Trial Activity
331 trials
Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage
Recruiting·—·Phase 4·NCT06119061·20 enrolled
The Effects of Various Concentrations of Ropivacaine on the Onset and Duration of Ankle Blocks
Recruiting·—·N/A·NCT06185608·174 enrolled
Chest CT Using Low-concentration Iodine Contrast Media
Recruiting·—·Phase 4·NCT05967117·370 enrolled
Page 1 of 23
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)